Passive immunization with monoclonal antibodies specific for lipopolysaccharide (LPS) O-side chain protects mice against intravenous Yersinia enterocolitica serotype O:3 infection

APMIS

Volumn 104, Issue 7-8, 1996, Pages 598-602

  Skurnik, Mikael ^a,b   Mikkola, Pasi ^a,c   Toivanen, Paavo ^a   Tertti, Risto ^a,c  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU CENTRE FOR BIOTECHNOLOGY   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Experimental infection; Immunization; Mice; Monoclonal antibody; Yersinia enterocolitica

Indexed keywords

LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL INFECTION; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; YERSINIA ENTEROCOLITICA;

EID: 0029989361     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1996.tb04917.x     Document Type: Article

References (22)

1. Acker, G., Knapp, W., Wartenberg, K. & Mayer, H.: Localization of enterobacterial common antigen in Yersinia enterocolitica by the immunoferritin technique. J. Bacteriol 147: 602-611, 1981.
2. Al-Hendy, A., Toivanen, P. & Skurnik, M.: The effect of growth temperature on the biosynthesis of Yersinia enterocolitica O:3 lipopolysaccharide: temperature regulates the transcription of the rfb but not of the rfa region. Microb. Pathog. 10: 81-86, 1991.
3. Al-Hendy, A., Toivanen, P. & Skurnik, M.: Expression cloning of Yersinia enterocolitica O:3 rfb gene cluster in Escherichia coli K12. Microb. Pathog. 10: 41-59, 1991.
4. Al-Hendy, A., Toivanen, P. & Skurnik, M.: Lipopolysaccharide O side chain of Yersinia enterocolitica O:3 is an essential virulence factor in an orally infected murine model. Infect. Immun. 60: 870-875, 1992.
5. Granfors, K.: Measurement of immunoglobulin M (IgM), IgG, and IgA antibodies against Yersinia enterocolitica by enzyme-linked immunosorbent assay: persistence of serum antibodies during disease. J. Clin. Microbiol. 9: 336-341, 1979.
6. Granfors, K., Ogasawara, M., Hill, J. L., Lahesmaa-Rantala, R., Toivanen, A. & Yu. D. T. Y.: Analysis of IgA antibodies to lipopolysaccharide in Yersinia-triggered reactive arthritis. J. Infect. Dis. 159: 1142-1147, 1989.
7. Hoffman, J., Lindberg, B. & Brubaker, R. R.: Structural studies of the O-specific side-chains of the lipopolysaccharide from Yersinia enterocolitica Ye 128. Carbohydr. Res. 78: 212-214, 1980.
8. Kawaoka, Y., Otsuki, K. & Tsubokura, M.: Serological evidence that Yersinia enterocolitica lipopolysaccharide produced during growth in vivo resembles that produced during growth in vitro at 25°C. J. Gen. Microbiol. 129: 2749-2751, 1983.
9. Pekkola-Heino, K., Viljanen, M. K., Ståhlberg, T. H., Granfors, K. & Toivanen, A.: Monoclonal antibodies reacting selectively with core and O-polysaccharide of Yersinia enterocolitica O:3 lipopolysaccharide. APMIS 95: 27-34, 1987.
10. Peterson, G. L.: Determination of total protein. Methods Enzymol. 91: 95-119, 1983.
11. Radziejewska-Lebrecht, J., Shashkov, A. S., Stroobant, V., Wartenberg, K., Warth, C. & Mayer, H.: The inner core region of Yersinia enterocolitica Ye75R (0:3) lipopolysaccharide. Eur. J. Biochem. 221: 343-351, 1994.
12. Reed, L. J. & Muench, H.: A simple method of estimating fifty percent endpoint. Am. J. Hyg. 27: 493-497, 1938.
13. Reeves, P.: Role of O-antigen variation in the immune response. Trends Microbiol. 3: 381-386, 1995.
14. Robins-Browne, R. M. & Prpic, J. K.: Effects of iron and desferrioxamine on infections with Yersinia enterocolitica. Infect. Immun. 47: 774-779, 1985.
15. Shashkov, A. S., Radziejewska-Lebrecht, J., Kochanowski, H. & Mayer, H.: The chemical structure of the outer core region of the Yersinia enterocolitica O:3 lipopolysaccharide. Abstract BO17, 8th European Carbohydrate Symposium, Sevilla, Spain, 1995.
16. Skurnik, M.: Lack of correlation between the presence of plasmids and fimbriae in Yersinia enterocolitica and Yersinia pseudotuberculosis. J. Appl. Bact. 56: 355-363, 1984.
17. Skurnik, M., Al-Hendy, A. & Toivanen, P.: Complement activation by Yersinia enterocolitica. Role of YadA and lipopolysaccharide O-side chain. Unpublished.
18. Skurnik, M., Venho, R., Toivanen, P. & Al-Hendy, A.: A novel locus of Yersinia enterocolitica serotype O:3 involved in lipopolysaccharide outer core biosynthesis. Mol. Microbiol. 17: 575-594, 1995.
19. Tertti, R., Eerola, E., Granfors, A., Lahesmaa-Rantala, R., Pekkola-Heino, K. & Toivanen, A.: Role of antibodies in the opsonization of Yersinia spp. Infect. Immun. 56: 1295-1300, 1988.
20. Tertti, R., Eerola, E., Lehtonen, O.-P., Ståhlberg, T., Viander, M. & Toivanen, A.: Virulence-plasmid is associated with the inhibition of opsonization in Yersinia enterocolitica and Yersinia pseudotuberculosis. Clin. Exp. Immunol. 68: 266-274, 1987.
21. Wachter, E. & Brade, V.: Influence of surface modulations by enzymes and monoclonal antibodies on alternative complement pathway activation by Yersinia enterocolitica. Infect. Immun. 57: 1984-1989, 1989.
22. Zhang, L., Al-Hendy, A., Toivanen, P. & Skurnik, M.: Genetic organization and sequence of the rfb gene cluster of Yersinia enterocolitica serotype O:3: Similarities to the dTDP-L-rhamnose biosynthesis pathway of Salmonella and to the bacterial polysaccharide transport systems. Mol. Microbiol. 9: 309-321, 1993.